P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 220,849 shares at $364.75 ($81.1M) on 2018-07-10, disclosed to the SEC on 2018-07-11.
Open-market sale of $81.1M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 610 | $0 | 0.0% |
| 2 | $370.52 | 78,604 | $29.1M | 35.9% |
| 3 | $364.75 | 900 | $328K | 0.4% |
| 4 | $365.56 | 17,221 | $6.3M | 7.8% |
| 5 | $365.56 | 17,221 | $6.3M | 7.8% |
| 6 | $366.49 | 24,339 |
| $8.9M |
| 11.0% |
| 7 | $366.49 | 24,339 | $8.9M | 11.0% |
| 8 | $367.40 | 6,405 | $2.4M | 2.9% |
| 9 | $368.61 | 12,211 | $4.5M | 5.5% |
| 10 | $368.61 | 12,211 | $4.5M | 5.5% |
| 11 | $369.41 | 13,194 | $4.9M | 6.0% |
| 12 | $369.41 | 13,194 | $4.9M | 6.0% |
| 13 | $370.17 | 100 | $37K | 0.0% |
| 14 | $371.29 | 300 | $111K | 0.1% |
| Total | $367.38 avg | 220,849 | $81.1M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |